Asthma meds have become shockingly unaffordable − but relief may be on the way

An inhaler that costs nearly $300 in the US goes for just $9 in Germany. What gives?

Ana Santos Rutschman, Professor of Law, Villanova School of Law • conversation
March 8, 2024 • ~7 min

COVID-19 vaccine mandates have come and mostly gone in the US – an ethicist explains why their messy rollout matters for trust in public health

Vaccine policies fall on a spectrum, from mandates to recommendations. Deciding what to use and when is not so much a science but a balancing act between personal autonomy and public good.

Rachel Gur-Arie, Assistant Professor of Nursing and Health Innovation, Arizona State University • conversation
Oct. 18, 2023 • ~9 min

Medicaid coverage is expiring for millions of Americans – but there's a proven way to keep many of them insured

Evidence from Massachusetts suggests that a multistep process discourages enrollment. The findings could help policymakers stave off a sharp decline in coverage when COVID-19 policies change.

Mark Shepard, Associate Professor of Public Policy, Harvard Kennedy School • conversation
Jan. 31, 2023 • ~5 min

Tomorrow's COVID safety guidelines will be different from today's – but that doesn't mean yesterday's were wrong

The constantly changing COVID-19 rules can be frustrating. But this pandemic is like no other public health crisis in history. It is better to think of the virus and US responses the way we think about hurricanes.

Michael Williams, Associate Professor of Surgery and Public Policy, University of Virginia • conversation
April 1, 2022 • ~9 min

A medical moonshot would help fix inequality in American health care

Medical innovations paired with innovative programs to get them to Black, Indigenous and Hispanic Americans can help close the health inequality gap.

Reginald Tucker-Seeley, Assistant Professor of Gerontology and Edward L. Schneider Chair in Gerontology, University of Southern California • conversation
July 1, 2021 • ~8 min

Non-COVID-19 doctor visits drop during pandemic

Non-COVID-19 doctor visits declined about 40% during the first six weeks or so of the pandemic. Stay-at-home orders likely played a significant role.

Mary Keck-Indiana • futurity
Aug. 6, 2020 • ~5 min

Coronavirus deaths in San Francisco vs. New York: What causes such big differences in cities' tolls?

Why one city suffers significantly more deaths than another isn't always obvious. A simple experiment shows how failing to consider certain factors can point policy makers in the wrong direction.

Brian W. Whitcomb, Associate Professor of Epidemiology, University of Massachusetts Amherst • conversation
June 2, 2020 • ~7 min

/

1